Report Detail

Other Global COVID-19 Saliva Screening Test Market Growth (Status and Outlook) 2021-2026

  • RnM4350265
  • |
  • 29 October, 2021
  • |
  • Global
  • |
  • 100 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

According to this latest study, the 2021 growth of COVID-19 Saliva Screening Test will have significant change from previous year. By the most conservative estimates of global COVID-19 Saliva Screening Test market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the COVID-19 Saliva Screening Test market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Saliva Screening Test market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Fluorescence-labelled Antigen
RT-PCR
CRISPR-Cas9

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Clinic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Psomagen, Inc
ARUP Labs
Vatic Health
MOgene
Fluidigm Corporation
Phosphorus Diagnostics LLC
Quidel Corporation
Abbot Laboratories
FLuroTech Ltd
LumiraDX
Gravity Diagnostics
Ambry Genetics
DxTerity Diagnostics


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global COVID-19 Saliva Screening Test Market Size 2016-2026
    • 2.1.2 COVID-19 Saliva Screening Test Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 COVID-19 Saliva Screening Test Segment by Type
    • 2.2.1 Fluorescence-labelled Antigen
    • 2.2.2 Fluorescence-labelled Antigen
    • 2.2.3 CRISPR-Cas9
  • 2.3 COVID-19 Saliva Screening Test Market Size by Type
    • 2.3.1 Global COVID-19 Saliva Screening Test Market Size CAGR by Type
    • 2.3.2 Global COVID-19 Saliva Screening Test Market Size Market Share by Type (2016-2021)
  • 2.4 COVID-19 Saliva Screening Test Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Clinic
    • 2.4.3 Others
  • 2.5 COVID-19 Saliva Screening Test Market Size by Application
    • 2.5.1 Global COVID-19 Saliva Screening Test Market Size CAGR by Application
    • 2.5.2 Global COVID-19 Saliva Screening Test Market Size Market Share by Application (2016-2021)

3 COVID-19 Saliva Screening Test Market Size by Players

  • 3.1 COVID-19 Saliva Screening Test Market Size Market Share by Players
    • 3.1.1 Global COVID-19 Saliva Screening Test Revenue by Players (2019-2021E)
    • 3.1.2 Global COVID-19 Saliva Screening Test Revenue Market Share by Players (2019-2021E)
  • 3.2 Global COVID-19 Saliva Screening Test Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 COVID-19 Saliva Screening Test by Regions

  • 4.1 COVID-19 Saliva Screening Test Market Size by Regions (2016-2021)
  • 4.2 Americas COVID-19 Saliva Screening Test Market Size Growth (2016-2021)
  • 4.3 APAC COVID-19 Saliva Screening Test Market Size Growth (2016-2021)
  • 4.4 Europe COVID-19 Saliva Screening Test Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa COVID-19 Saliva Screening Test Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas COVID-19 Saliva Screening Test Market Size by Country (2016-2021)
  • 5.2 Americas COVID-19 Saliva Screening Test Market Size by Type (2016-2021)
  • 5.3 Americas COVID-19 Saliva Screening Test Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC COVID-19 Saliva Screening Test Market Size by Region (2016-2021)
  • 6.2 APAC COVID-19 Saliva Screening Test Market Size by Type (2016-2021)
  • 6.3 APAC COVID-19 Saliva Screening Test Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe COVID-19 Saliva Screening Test by Country (2016-2021)
  • 7.2 Europe COVID-19 Saliva Screening Test Market Size by Type (2016-2021)
  • 7.3 Europe COVID-19 Saliva Screening Test Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa COVID-19 Saliva Screening Test by Region (2016-2021)
  • 8.2 Middle East & Africa COVID-19 Saliva Screening Test Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa COVID-19 Saliva Screening Test Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global COVID-19 Saliva Screening Test Market Forecast

  • 10.1 Global COVID-19 Saliva Screening Test Forecast by Regions (2021-2026)
    • 10.1.1 Global COVID-19 Saliva Screening Test Forecast by Regions (2021-2026)
    • 10.1.2 Americas COVID-19 Saliva Screening Test Forecast
    • 10.1.3 APAC COVID-19 Saliva Screening Test Forecast
    • 10.1.4 Europe COVID-19 Saliva Screening Test Forecast
    • 10.1.5 Middle East & Africa COVID-19 Saliva Screening Test Forecast
  • 10.2 Americas COVID-19 Saliva Screening Test Forecast by Countries (2021-2026)
    • 10.2.1 United States COVID-19 Saliva Screening Test Market Forecast
    • 10.2.2 Canada COVID-19 Saliva Screening Test Market Forecast
    • 10.2.3 Mexico COVID-19 Saliva Screening Test Market Forecast
    • 10.2.4 Brazil COVID-19 Saliva Screening Test Market Forecast
  • 10.3 APAC COVID-19 Saliva Screening Test Forecast by Region (2021-2026)
    • 10.3.1 China COVID-19 Saliva Screening Test Market Forecast
    • 10.3.2 Japan COVID-19 Saliva Screening Test Market Forecast
    • 10.3.3 Korea COVID-19 Saliva Screening Test Market Forecast
    • 10.3.4 Southeast Asia COVID-19 Saliva Screening Test Market Forecast
    • 10.3.5 India COVID-19 Saliva Screening Test Market Forecast
    • 10.3.6 Australia COVID-19 Saliva Screening Test Market Forecast
  • 10.4 Europe COVID-19 Saliva Screening Test Forecast by Country (2021-2026)
    • 10.4.1 Germany COVID-19 Saliva Screening Test Market Forecast
    • 10.4.2 France COVID-19 Saliva Screening Test Market Forecast
    • 10.4.3 UK COVID-19 Saliva Screening Test Market Forecast
    • 10.4.4 Italy COVID-19 Saliva Screening Test Market Forecast
    • 10.4.5 Russia COVID-19 Saliva Screening Test Market Forecast
  • 10.5 Middle East & Africa COVID-19 Saliva Screening Test Forecast by Region (2021-2026)
    • 10.5.1 Egypt COVID-19 Saliva Screening Test Market Forecast
    • 10.5.2 South Africa COVID-19 Saliva Screening Test Market Forecast
    • 10.5.3 Israel COVID-19 Saliva Screening Test Market Forecast
    • 10.5.4 Turkey COVID-19 Saliva Screening Test Market Forecast
    • 10.5.5 GCC Countries COVID-19 Saliva Screening Test Market Forecast
  • 10.6 Global COVID-19 Saliva Screening Test Forecast by Type (2021-2026)
  • 10.7 Global COVID-19 Saliva Screening Test Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Psomagen, Inc
    • 11.1.1 Psomagen, Inc Company Information
    • 11.1.2 Psomagen, Inc COVID-19 Saliva Screening Test Product Offered
    • 11.1.3 Psomagen, Inc COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Psomagen, Inc Main Business Overview
    • 11.1.5 Psomagen, Inc Latest Developments
  • 11.2 ARUP Labs
    • 11.2.1 ARUP Labs Company Information
    • 11.2.2 ARUP Labs COVID-19 Saliva Screening Test Product Offered
    • 11.2.3 ARUP Labs COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 ARUP Labs Main Business Overview
    • 11.2.5 ARUP Labs Latest Developments
  • 11.3 Vatic Health
    • 11.3.1 Vatic Health Company Information
    • 11.3.2 Vatic Health COVID-19 Saliva Screening Test Product Offered
    • 11.3.3 Vatic Health COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Vatic Health Main Business Overview
    • 11.3.5 Vatic Health Latest Developments
  • 11.4 MOgene
    • 11.4.1 MOgene Company Information
    • 11.4.2 MOgene COVID-19 Saliva Screening Test Product Offered
    • 11.4.3 MOgene COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 MOgene Main Business Overview
    • 11.4.5 MOgene Latest Developments
  • 11.5 Fluidigm Corporation
    • 11.5.1 Fluidigm Corporation Company Information
    • 11.5.2 Fluidigm Corporation COVID-19 Saliva Screening Test Product Offered
    • 11.5.3 Fluidigm Corporation COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Fluidigm Corporation Main Business Overview
    • 11.5.5 Fluidigm Corporation Latest Developments
  • 11.6 Phosphorus Diagnostics LLC
    • 11.6.1 Phosphorus Diagnostics LLC Company Information
    • 11.6.2 Phosphorus Diagnostics LLC COVID-19 Saliva Screening Test Product Offered
    • 11.6.3 Phosphorus Diagnostics LLC COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Phosphorus Diagnostics LLC Main Business Overview
    • 11.6.5 Phosphorus Diagnostics LLC Latest Developments
  • 11.7 Quidel Corporation
    • 11.7.1 Quidel Corporation Company Information
    • 11.7.2 Quidel Corporation COVID-19 Saliva Screening Test Product Offered
    • 11.7.3 Quidel Corporation COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Quidel Corporation Main Business Overview
    • 11.7.5 Quidel Corporation Latest Developments
  • 11.8 Abbot Laboratories
    • 11.8.1 Abbot Laboratories Company Information
    • 11.8.2 Abbot Laboratories COVID-19 Saliva Screening Test Product Offered
    • 11.8.3 Abbot Laboratories COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Abbot Laboratories Main Business Overview
    • 11.8.5 Abbot Laboratories Latest Developments
  • 11.9 FLuroTech Ltd
    • 11.9.1 FLuroTech Ltd Company Information
    • 11.9.2 FLuroTech Ltd COVID-19 Saliva Screening Test Product Offered
    • 11.9.3 FLuroTech Ltd COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 FLuroTech Ltd Main Business Overview
    • 11.9.5 FLuroTech Ltd Latest Developments
  • 11.10 LumiraDX
    • 11.10.1 LumiraDX Company Information
    • 11.10.2 LumiraDX COVID-19 Saliva Screening Test Product Offered
    • 11.10.3 LumiraDX COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 LumiraDX Main Business Overview
    • 11.10.5 LumiraDX Latest Developments

11. Gravity Diagnostics

  • 11.11.1 Gravity Diagnostics Company Information
  • 11.11.2 Gravity Diagnostics COVID-19 Saliva Screening Test Product Offered
  • 11.11.3 Gravity Diagnostics COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 Gravity Diagnostics Main Business Overview
  • 11.11.5 Gravity Diagnostics Latest Developments
  • 11.12 Ambry Genetics
    • 11.12.1 Ambry Genetics Company Information
    • 11.12.2 Ambry Genetics COVID-19 Saliva Screening Test Product Offered
    • 11.12.3 Ambry Genetics COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Ambry Genetics Main Business Overview
    • 11.12.5 Ambry Genetics Latest Developments
  • 11.13 DxTerity Diagnostics
    • 11.13.1 DxTerity Diagnostics Company Information
    • 11.13.2 DxTerity Diagnostics COVID-19 Saliva Screening Test Product Offered
    • 11.13.3 DxTerity Diagnostics COVID-19 Saliva Screening Test Revenue, Gross Margin and Market Share (2019-2021)
    • 11.13.4 DxTerity Diagnostics Main Business Overview
    • 11.13.5 DxTerity Diagnostics Latest Developments
  • 12 Research Findings and Conclusion

    Summary:
    Get latest Market Research Reports on COVID-19 Saliva Screening Test . Industry analysis & Market Report on COVID-19 Saliva Screening Test is a syndicated market report, published as Global COVID-19 Saliva Screening Test Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of COVID-19 Saliva Screening Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,772.00
    5,544.00
    3,241.00
    6,482.00
    529,725.00
    1,059,450.00
    291,900.00
    583,800.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report